QIAGEN Acquires Intelligent Bio-Systems to Enter Next-Generation Sequencing Market

Yesterday it was announced that a Norwich portfolio company, Intelligent Bio-Systems, was acquired by QIAGEN (NASDAQ: QGEN). Using the technology developed by Intelligent Bio-Systems, QIAGEN plans to enter the next-generation sequencing market. It’s an exciting opportunity and we wish them great success.

You can read the press release at http://www.prnewswire.com/news-releases/qiagen-unveils-initiative-to-create-next-generation-sequencing-portfolio-for-use-in-clinical-research-and-molecular-diagnostics-160283625.html